Enjoy this free share recommendation on Advanced Oncotherapy extracted from the latest edition of the premium Trendwatch newsletter… Proton beam therapy is coming to the...
Strip out its cash pile and Crossrider is really good value: enjoy this free share recommendation on Crossrider extracted from the latest edition of the premium Trendwatch...
Enjoy this free share recommendation on The Gym Group extracted from the latest edition of the premium Trendwatch newsletter… ARE YOU by any chance into keeping...
Enjoy this free share recommendation on K3 Capital Group extracted from the latest edition of the premium Trendwatch newsletter… THIS NEXT company is interesting in...
Enjoy this free share recommendation on XL Media extracted from the latest edition of the premium Trendwatch newsletter… FRANKLY, it’s becoming increasingly difficult...
Enjoy this free share recommendation on MTI Wireless Edge extracted from the latest edition of the premium Trendwatch newsletter… NEXT A great little AIM company…...
Enjoy this free share recommendation on Hummingbird Resources extracted from the latest edition of the premium Trendwatch newsletter… Hummingbird Resources is one of...
Enjoy this free share recommendation on ABZENA extracted from the latest edition of the premium Trendwatch newsletter… IT WOULD be churlish, if not actually unethical,...
Enjoy this free share recommendation on CRIMSON TIDE extracted from the latest edition of the premium Trendwatch newsletter… Crimson Tide is currently a tiny company,...
WE EXPECT – indeed we know – that many of our readers are well versed in the markets we serve. This is especially true of AIM. But reversion to the norm is the...